Arrow Epidural Needle KZ-05500-007(Luer); KZ-05500-009 (NRFit)
K190026 · Teleflex Medical · BSP · Aug 21, 2019 · Anesthesiology
Device Facts
| Record ID | K190026 |
| Device Name | Arrow Epidural Needle KZ-05500-007(Luer); KZ-05500-009 (NRFit) |
| Applicant | Teleflex Medical |
| Product Code | BSP · Anesthesiology |
| Decision Date | Aug 21, 2019 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 868.5150 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Intended Use
The Arrow Epidural Needles are intended to inject local anesthetic into a patient to provide regional anesthesia or to facilitate the placement of an epidural catheter.
Device Story
Arrow Epidural Needles are sterile, single-use, disposable devices used by clinicians to deliver local anesthetics for regional anesthesia or to facilitate epidural catheter placement. The device consists of a stainless steel cannula with a plastic hub (integrated wings) and a plastic stylet; the stylet prevents tissue coring during insertion. The needle assembly includes a protective guard. The device features either a standard Luer connector or an ISO 80369-6 NRFit connector. Clinicians manually insert the needle into the patient's epidural space. The device provides a pathway for anesthetic delivery or catheter threading, directly supporting the administration of regional anesthesia to manage patient pain.
Clinical Evidence
Bench testing only. No clinical data provided. Testing included mechanical performance (tensile strength, stiffness, resistance to breakage/corrosion), connector integrity (Luer and NRFit), biocompatibility (cytotoxicity, sensitization, irritation, acute systemic toxicity, material-mediated pyrogenicity), bacterial endotoxin testing, and packaging stability/distribution simulation.
Technological Characteristics
304 stainless steel cannula; clear acrylic needle hub; clear polypropylene stylet cannula; gray polypropylene stylet hub. Features Tuohy tip design. Connectivity via ISO 594 Luer or ISO 80369-6 NRFit connectors. Sterilized via Ethylene Oxide. Single-use, disposable. Complies with BS 6196 (joint strength), ISO 9626 (stiffness/breakage/corrosion), and ISO 10993 (biocompatibility).
Indications for Use
Indicated for patients requiring regional anesthesia via local anesthetic injection or epidural catheter placement.
Regulatory Classification
Identification
An anesthesia conduction needle is a device used to inject local anesthetics into a patient to provide regional anesthesia.
Predicate Devices
- AN-E Epidural Needle (K131006)
Related Devices
- K053318 — RX EPIDURAL NEEDLE · Epimed International, Inc. · Feb 17, 2006
- K150266 — Remington Medical Inc. Tuohy Epidural Needles · Remington Medical, Inc. · Jun 4, 2015
- K203668 — RELI NRFit Epidural Needles, Phoenix NRFit Epidural Needles, RELI NRFit Spinal Needles, Phoenix NRFit Spinal Needles · Myco Medical Supplies, Inc. · Sep 29, 2021
- K090261 — PORTEX TUOHY EPIDURAL NEEDLE 17G, PORTEX TUOHY EPIDURAL NEEDLE 18G · Smiths Medical Asd, Inc. · May 1, 2009
- K061394 — SPECIALTY NEEDLES (SPINAL NEEDLE, PENCIL POINT SPINAL NEEDLE, EPIDURAL NEEDLE) · Busse Hospital Disposables, Inc. · Sep 6, 2006
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo features the letters 'FDA' in a blue square, followed by the words 'U.S. FOOD & DRUG' and 'ADMINISTRATION' in blue text.
August 21, 2019
Teleflex Medical Lakshmi Kanuri Regulatory Affairs Specialist 3015 Carrington Mill Blvd Morrisville, North Carolina 27560
Re: K190026
Trade/Device Name: Arrow Epidural Needle Regulation Number: 21 CFR 868.5150 Regulation Name: Anesthesia Conduction Needle Regulatory Class: Class II Product Code: BSP Dated: July 19, 2019 Received: July 22, 2019
Dear Lakshmi Kanuri:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
{1}------------------------------------------------
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Todd Courtney Assistant Director DHT1C: Division of ENT, Sleep Disordered Breathing, Respiratory and Anesthesia Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
# Indications for Use
510(k) Number (if known) K190026
Device Name Arrow Epidural Needles
Indications for Use (Describe)
The Arrow Epidural Needles are intended to inject local anesthetic into a patient to provide regional anesthesia or to facilitate the placement of an epidural catheter.
| Type of Use (Select one or both, as applicable) |
|-------------------------------------------------|
| |
X Prescription Use (Part 21 CFR 801 Subpart D)
| | Over-The-Counter Use (21 CFR 801 Subpart C)
#### CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
## 510(k) SUMMARY
# K190026
### 1. Name, Address, Phone and Fax Number of Applicant
Teleflex Medical, Incorporated 3015 Carrington Mill Blvd Morrisville, NC 27560 USA Phone: 919-361-4087 Fax: 919-433-4996
### 2. Contact Person
Lakshmi Kanuri Regulatory Affairs Specialist
#### 3. Date Prepared
August 21, 2019
#### 4. Device Name
| Trade Name: | Arrow Epidural Needles |
|----------------------|------------------------------------------------|
| Classification Name: | Anesthesia conduction needle (w/wo introducer) |
| FDA Product Code: | BSP |
| CFR Number: | 868.5150 |
| Regulatory Class: | II |
#### 5. Predicate Device
K131006 - AN-E Epidural Needle
#### 6. Device Description
The Arrow Epidural Needles are sterile, single use, disposable devices. They are used for the injection of anesthetic agents into a patient for regional anesthesia administration or to facilitate the placement of an epidural catheter for continuous infusion of local anesthetics.
The Arrow Epidural Needles consist of a plastic cannula hub with integrated wings that come with either Luer Connector and NRFit Connector, stainless steel cannula, and plastic stylet. The purpose of the stylet is to prevent tissue coring during needle insertion. The needle assembly is protected with a guard to prevent damage to the needle.
#### 7. Indications for Use
The Arrow Epidural Needles are intended to inject local anesthetic into a patient to provide regional anesthesia or to facilitate the placement of an epidural catheter.
{4}------------------------------------------------
| CHARACTERISTIC | PREDICATE DEVICE<br>K131006 | SUBJECT DEVICE |
|-------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Applicant Name | LCCS PRODUCTS<br>LIMITED | ARROW INTERNATIONAL<br>INC. |
| Device Classification Name | Anesthesia conduction<br>needle<br>(w/wo introducer) | Anesthesia conduction needle<br>(w/wo introducer) |
| FDA Product Code | BSP | BSP |
| CFR Number | 868.5150 | 868.5150 |
| Regulatory Class | II | II |
| Trade Name | AN-E Epidural Needle | Arrow Epidural Needle |
| Intended Use/Indications for<br>Use | Intended for the transient<br>delivery of anesthetics to<br>provide neuraxial<br>anesthetics or to facilitate<br>placement of an epidural<br>catheter. | The Arrow Epidural Needles<br>are intended to inject local<br>anesthetic into a patient to<br>provide regional anesthesia or<br>to facilitate the placement of an<br>epidural catheter. |
| Needle Guage Size | 15 GA - 20 GA | 17 GA |
| Needle Length | 50 mm - 150 mm | 88.9mm (8.89 cm) (3-1/2") |
| Tip Design | Tuohy, Quincke, Pencil<br>Point | Tuohy |
| Needle Cannula Material | 304 Stainless Steel | 304 Stainless Steel |
| Needle Hub Material | K-Resin KR03 | Clear Acrylic |
| Stylet Cannula Material | 304 STAINLESS STEEL | Clear Polypropylene |
| Stylet Hub Material | HDPE | Gray Polypropylene |
| Connector Type | ISO 594 Luer | ISO 594 Luer<br>ISO 80369-6 NRFit |
| Final Needle Assembly<br>Protection | Not stated | Guard |
| CHARACTERISTIC | PREDICATE DEVICE K131006 | SUBJECT DEVICE |
| Markings | Not stated | 1 cm (10 mm) |
| Performance | ISO 7864 Hub to Needle Bond Strength<br>ISO 9626 Stiffness<br>ISO 9626 Resistance to breakage<br>ISO 594-1 and ISO 594-2 Luer Connector | BS 6196 Joint Between the Needle Hub and Needle Cannula and Joint Between the Stylet Hub and Stylet Cannula<br>ISO 9626 Stiffness<br>ISO 9626 Resistance to breakage<br>ISO 9626 Resistance to corrosion<br>ISO 594-1 and ISO 594-2 Luer Connector<br>ISO 80369-6 NRFit Connector |
| Method of Sterilization | Not stated | Ethylene Oxide |
| Shelf Life | Not stated | One year |
| Packaging | Not stated | Tyvek Pouch |
## 8. Technological Characteristics Comparison to the predicate
{5}------------------------------------------------
{6}------------------------------------------------
### 9. Performance Data
A summary of tests relied upon to demonstrate substantial equivalence to the predicate can be found in the Table below
| Test | Standard (if applicable) | Principle of Test |
|----------------------------------------------------------------------------------------------------|---------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Joint Between the Needle Hub and Needle Cannula<br>Joint Between the Stylet Hub and Stylet Cannula | BS 6196 | A tensile force is applied for a specified time to the union being tested, and the union observed to determine if it parts. |
| Stiffness | ISO 9626 | A specified force is applied to the centre of the specified length of tubing, which is supported at both ends, and the amount of deflection measured. |
| Resistance to breakage | ISO 9626 | One end of the tubing is firmly fixed, and a force applied to the tubing at a specified distance from the point of fixation, so as to bend the tubing through a specified angle, first in one direction and then in the opposite direction, for a specified number of cycles. |
| Resistance to corrosion | ISO 9626 | The tubing is partially immersed in sodium chloride solution for a specified time and afterwards the immersed portion compared visually with the un immersed portion for signs of corrosion. |
| Luer Connector | ISO 594-1<br>ISO 594-2 | To test unscrewing gauging, liquid leakage, air leakage, separation force. |
| NRFit Connector | ISO 80369-6 | To test unscrewing gauging, liquid leakage, air leakage, separation force. |
| Biocompatibility | ISO 10993 | Testing included Cytotoxicity, Sensitization, Irritation, Acute Systemic Toxicity and Material Mediated Pyrogenicity |
| LAL Bacterial Endotoxin | AAMI ST72 | LAL Bacterial Endotoxin testing of medical devices that have contact with CSF |
| Packaging | ISO 11607-1<br>ASTM D4169 | Stability and Distribution simulation testing |
### 10. Conclusion
The Arrow Epidural Needle has similar indications for use and technology of construction as the predicate device. Performance test results demonstrate that the proposed device meets its intended use. It is for these reasons that the proposed device is substantially equivalent to the proposed predicate device and does not raise different questions of safety and effectiveness.